Lamivudine as a Novel Clinical Effort for Rett Syndrome | MicrobiomeTrials← Back to trialsNCT07640503
Lamivudine as a Novel Clinical Effort for Rett Syndrome
ENROLLING_BY_INVITATIONPHASE2INTERVENTIONAL
Trial Details
Start: 2025-11-05Est. Completion: 2027-06
Enrollment target: 10 participants Locations- GenClinics, Fortaleza, Ceará, Brazil
Other microbiome trials you might be interested in
Rett Syndrome
This study will evaluate the efficacy and safety profiles of the investigational gene therapy, NGN-401, in females with …
Birmingham, United StatesEst. completion Dec 2029
Rett Syndrome
The purpose of this study is to investigate the efficacy of fenfluramine hydrochloride (HCl) versus placebo in study par…
Little Rock, United StatesEst. completion Aug 1, 2028